Validation of a linear dosing nomogram for enoxaparin anti-Xa levels

被引：0
|
作者：
Currie, Janna L. [1 ]
Huggins, Jenna M. [2 ]
Allender, J. Erin [2 ]
Barakat, Oksana [2 ]
机构：
[1] Campbell Univ, Coll Pharm & Hlth Sci, Cary, NC USA
[2] WakeMed Hlth & Hosp, Raleigh, NC USA
来源：
PHARMACOTHERAPY | 2012年 / 32卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
354
引用
收藏
页码：E282 / E282
页数：1
相关论文
共 50 条
  • [41] A case series of LMWH use in pregnancy: Should trough anti-Xa levels guide dosing?
    Berresheim, Michelle
    Wilkie, Jodi
    Nerenberg, Kara A.
    Ibrahim, Quazi
    Bungard, Tammy J.
    [J]. THROMBOSIS RESEARCH, 2014, 134 (06) : 1234 - 1240
  • [42] Standard Prophylactic Enoxaparin Dosing Leads to Inadequate Anti-Xa Levels and Increased Deep Venous Thrombosis Rates in Critically Ill Trauma and Surgical Patients
    Malinoski, Darren
    Jafari, Fariba
    Ewing, Tyler
    Ardary, Chris
    Conniff, Heather
    Baje, Mark
    Kong, Allen
    Lekawa, Michael E.
    Dolich, Matthew O.
    Cinat, Marianne E.
    Barrios, Cristobal
    Hoyt, David B.
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2010, 68 (04): : 874 - 879
  • [43] Enoxaparin Thromboprophylaxis Dosing and Anti-Factor Xa Levels in Low-Weight Patients
    Yam, Lily
    Bahjri, Khaled
    Geslani, Van
    Cotton, Adrian
    Hong, Lisa
    [J]. PHARMACOTHERAPY, 2019, 39 (07): : 749 - 755
  • [44] Validation of an assay for determination of anti-xa activity of Rivaroxaban
    Delavenne, X.
    Meuley, R.
    Baylot, D.
    Mismetti, P.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 965 - 966
  • [45] LABORATORY VALIDATION OF A CHROMOGENIC ANTI-XA ASSAY FOR APIXABAN
    Leger, Rachel R.
    Tange, Julie I.
    McBane, Robert D.
    Chen, Dong
    Pruthi, Rajiv K.
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E36 - E37
  • [46] Anti-Xa activity relates to outcome in acute coronary syndromes treated with Enoxaparin
    Montalescot, G
    Collet, JP
    Payot, L
    Choussat, R
    Beygui, F
    Gallois, V
    Metzger, JP
    Thomas, D
    [J]. CIRCULATION, 2003, 108 (17) : 501 - 501
  • [47] Standard Prophylactic Enoxaparin Dosing Leads to Inadequate Anti-Xa Levels and Increased Deep Venous Thrombosis Rates in Critically Ill Trauma and Surgical Patients DISCUSSION
    Livingston, David H.
    Malinoski, Darren J.
    Raghavendran, Krishnan
    Ochsner, Gage M., Jr.
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2010, 68 (04): : 879 - 880
  • [48] Comparison of Anti-Xa Levels in Obese and Non-Obese Pediatric Patients Receiving Treatment Doses of Enoxaparin
    Richard, Ashley A.
    Kim, Shelly
    Moffett, Brady S.
    Bomgaars, Lisa
    Mahoney, Donald, Jr.
    Yee, Donald L.
    [J]. JOURNAL OF PEDIATRICS, 2013, 162 (02): : 293 - 296
  • [49] ANTI-XA MONITORING OF THERAPEUTIC ENOXAPARIN IN PATIENTS WEIGHING AT LEAST 90 KILOGRAMS
    Hur, Mina
    Kim, Hanah
    Park, Mikyoung
    Chung, Hee-Jung
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 2018, 93 (09) : E26 - E27
  • [50] Anti-Xa based dosing of enoxaparin in hematopoietic stem cell transplant and adoptive cell therapy patients: A single center experience
    Jizzini, Mazen
    Akhtar, Othman Salim
    Atwood, Kris
    Ji, Wenyan
    Pleskow, Jordan
    Bat, Taha
    Balderman, Sophia
    [J]. THROMBOSIS RESEARCH, 2022, 211 : 6 - 9
12345